CMS is proposing new prior-authorization rules for drugs that could shorten waits, improve denial notices, and expand electronic processing across Medicare Advantage, Medicaid, CHIP, and federally facilitated ACA marketplace plans. Some changes are already in motion, but the drug-related requirements would not take effect until 2027 unless CMS finalizes and implements the rule.
The FDA says IQ Produce is recalling 150-gram enoki mushroom packages after a sample tested positive for Listeria monocytogenes. No illnesses have been reported so far, but the recall matters most for pregnant people, older adults, and anyone with a weakened immune system.
The federal Dietary Guidelines for Americans have been updated, and the newest version is meant to be practical for everyday grocery shopping and meals. For most people, the big message is familiar: build meals around nutrient-dense foods and keep an eye on added sugars, sodium, and refined carbohydrates.
CMS has launched a five-year rural health program that will send money to every state starting in 2026. The key question for patients is whether states use the funds to improve local care, shorten travel times, and strengthen services people can actually reach.
The FDA says some TRUE METRIX blood glucose meters can show the same E-5 code for two different problems: a very high blood sugar reading or a test strip error. That confusion can delay treatment or lead to the wrong response. The agency says people should move to an alternative testing method if possible, but keep testing until a backup is ready.
CDC’s updated pneumococcal guidance now starts routine adult vaccination at age 50, so many Americans should re-check their records. Which shot is right depends on age, health risks, and which pneumococcal vaccines you may already have received.
The CDC’s updated nutrition guidance is a practical reminder to cut back on added sugars and sodium without trying to overhaul every meal at once. Small swaps — like water instead of sugary drinks and fruit or vegetables instead of sugary snacks — can add up over time. The advice is especially relevant for people with high blood pressure, diabetes, heart disease risk, and families trying to build healthier routines for children and teens.
The FDA says people using TRUE METRIX blood glucose systems should keep testing for now, but should transition to another meter when possible. The concern is an E-5 error code that can be confused with either a very high glucose reading or a test strip problem, which could delay the right response.
CMS has proposed new prior-authorization and interoperability rules that could speed up drug coverage decisions for some plans if finalized. The main promise is less waiting and more transparency — but the change is still only a proposal, and details can still change after public comment.
CDC says eligible adults can get an RSV vaccine at any time, but the best window is late summer or early fall, before RSV usually starts spreading in the community. Current guidance recommends one dose for adults 75 and older and for adults 50 to 74 who are at increased risk of severe RSV illness.
Bleeding gums are not something to ignore, even when they seem minor. Gum disease is common, and it can affect your mouth first — but it may also connect with other health conditions in ways worth discussing with your dentist. Here’s a plain-language guide to what gum disease is, which symptoms matter, what the evidence says about whole-body health links, and what questions to bring to a dental visit if you may be at higher risk.
A nationwide hospital-level recall is underway for one lot of magnesium sulfate after FDA said a pouch was found to contain tranexamic acid instead. The issue matters because both drugs are used in urgent care, but FDA said it had not received adverse-event reports at the time of the announcement.
High U.S. prescription drug costs are driven by a lack of price regulation, patent monopolies, and complex supply chain mechanics involving pharmacy benefit managers (PBMs) that incentivize high list prices. Infographics highlight that these factors, combined with extensive marketing spend over R&D, lead to soaring launch prices and increased patient cost-related non-adherence.
Measles is back on parents’ radar in 2026 because it spreads easily and can become serious, especially for young children and babies who are too young to be fully vaccinated. The good news is that the routine MMR vaccine schedule still offers strong protection, and there are clear steps to take after a possible exposure.
CMS has launched a $50 billion rural health program that will send money to all 50 states, but how much patients feel the benefit will depend on what states choose to fund. The first-year awards vary widely, and the dollars are meant to support access, workforce, telehealth, infrastructure, and other rural health priorities.
The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from a key bulk-substance list used by outsourcing compounding facilities. The move follows the agency’s view that national GLP-1 supply has stabilized and that the shortage-driven flexibility is no longer needed.
The FDA has issued two separate safety notices that may affect hospitals and patients: a nationwide recall of certain B. Braun Lactated Ringer’s Injection 1L lots because of particulate matter, and a shortage notice for neurosurgical patties, sponges and strips. The actions are different, but both can affect procedure planning, supply checks and patient safety.
CDC’s latest surveillance update shows measles is still spreading in the United States through multiple outbreaks, not fading into the background. The data do not mean most Americans are at immediate risk, but they do show why vaccination status, quick reporting, and early isolation still matter for families, schools, and workplaces.
Measles cases and outbreaks have continued in the U.S. in 2026. For parents of young children, the most practical steps are to know the early symptoms, check MMR vaccination status, and act quickly after any exposure.
CMS began enforcing updated hospital price-transparency rules on April 1, 2026. The changes are meant to make hospital pricing data more usable and comparable, but the files can still be hard to interpret and transparency does not guarantee lower bills.
CDC now recommends one RSV dose for adults 75 and older, and for adults 50 to 74 who are at increased risk of severe RSV illness. Here’s what changed, who may qualify, when vaccination makes the most sense, and what has not changed.
The FDA took two April 2026 steps that could matter to patients: it advanced early real-time clinical trial work and reminded more than 2,200 sponsors and researchers to report overdue results. The changes may improve transparency and speed up research, but they do not replace careful evidence review.
End of content
End of content